Cargando…
Prevalence and impact of myocardial injury among patients hospitalized with COVID-19
BACKGROUND: Myocardial injury is a prevalent complication observed in patients hospitalized with COVID-19 and is strongly associated with severe illness and in-hospital mortality. However, the long-term consequences of myocardial injury on clinical outcomes remain poorly understood. This study aimed...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433191/ https://www.ncbi.nlm.nih.gov/pubmed/37600048 http://dx.doi.org/10.3389/fcvm.2023.1202332 |
_version_ | 1785091594989338624 |
---|---|
author | Vu, Vu Hoang Nguyen, Thanh Cong Pham, Quang Dang Duy Pham, Dan Ngoc Le, Le Bao Le, Khoi Minh |
author_facet | Vu, Vu Hoang Nguyen, Thanh Cong Pham, Quang Dang Duy Pham, Dan Ngoc Le, Le Bao Le, Khoi Minh |
author_sort | Vu, Vu Hoang |
collection | PubMed |
description | BACKGROUND: Myocardial injury is a prevalent complication observed in patients hospitalized with COVID-19 and is strongly associated with severe illness and in-hospital mortality. However, the long-term consequences of myocardial injury on clinical outcomes remain poorly understood. This study aimed to assess the impact of myocardial injury on both acute-phase and long-term prognosis in COVID-19 patients. METHODS: A retrospective, observational study was conducted on all patients who received treatment at the Intensive Care Center for COVID-19 patient, University Medical Center Ho Chi Minh City (UCICC), from August 3rd, 2021, to October 28th, 2021. RESULTS: A total of 582 patients were enrolled in the study, of which 55.3% were female. The mean age of participants was 63.3 ± 16.2. Out of these patients, 330 cases (56.8%) showed myocardial injury. Compared to patients without myocardial injury, those with myocardial injury were older and had a higher incidence of chronic diseases including hypertension, ischemic heart disease, atrial fibrillation, heart failure, diabetes mellitus, chronic kidney disease. They also presented with more severe respiratory failure upon admission and showed a more pronounced abnormality in inflammation and kidney function tests. Furthermore, the in-hospital mortality rate was significantly higher in the group with myocardial injury (49.7% vs 14.3%, p < 0.001). After adjusting for age, gender, comorbidities, renal function, and disease severity at admission, myocardial injury emerged as an independent risk factor for in-hospital mortality (OR = 3.758, 95% CI 1.854–7.678, p < 0.001). Among successfully discharged COVID-19 patients, the all-cause mortality rate after a median follow-up of 18.4 months was 7.9%. Patients with myocardial injury had a significantly higher long-term mortality rate compared to those without myocardial injury (14.0% vs. 3.2%, p < 0.001). However, multivariable Cox regression analysis did not find myocardial injury to be a significant predictor of long-term mortality (HR = 2.128, 95% CI 0.792–5.712, p = 0.134). CONCLUSIONS: Myocardial injury is a common and serious complication in hospitalized COVID-19 patients, associated with increased in-hospital mortality. However, it does not significantly impact long-term mortality in successfully discharged COVID-19 patients. |
format | Online Article Text |
id | pubmed-10433191 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104331912023-08-18 Prevalence and impact of myocardial injury among patients hospitalized with COVID-19 Vu, Vu Hoang Nguyen, Thanh Cong Pham, Quang Dang Duy Pham, Dan Ngoc Le, Le Bao Le, Khoi Minh Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Myocardial injury is a prevalent complication observed in patients hospitalized with COVID-19 and is strongly associated with severe illness and in-hospital mortality. However, the long-term consequences of myocardial injury on clinical outcomes remain poorly understood. This study aimed to assess the impact of myocardial injury on both acute-phase and long-term prognosis in COVID-19 patients. METHODS: A retrospective, observational study was conducted on all patients who received treatment at the Intensive Care Center for COVID-19 patient, University Medical Center Ho Chi Minh City (UCICC), from August 3rd, 2021, to October 28th, 2021. RESULTS: A total of 582 patients were enrolled in the study, of which 55.3% were female. The mean age of participants was 63.3 ± 16.2. Out of these patients, 330 cases (56.8%) showed myocardial injury. Compared to patients without myocardial injury, those with myocardial injury were older and had a higher incidence of chronic diseases including hypertension, ischemic heart disease, atrial fibrillation, heart failure, diabetes mellitus, chronic kidney disease. They also presented with more severe respiratory failure upon admission and showed a more pronounced abnormality in inflammation and kidney function tests. Furthermore, the in-hospital mortality rate was significantly higher in the group with myocardial injury (49.7% vs 14.3%, p < 0.001). After adjusting for age, gender, comorbidities, renal function, and disease severity at admission, myocardial injury emerged as an independent risk factor for in-hospital mortality (OR = 3.758, 95% CI 1.854–7.678, p < 0.001). Among successfully discharged COVID-19 patients, the all-cause mortality rate after a median follow-up of 18.4 months was 7.9%. Patients with myocardial injury had a significantly higher long-term mortality rate compared to those without myocardial injury (14.0% vs. 3.2%, p < 0.001). However, multivariable Cox regression analysis did not find myocardial injury to be a significant predictor of long-term mortality (HR = 2.128, 95% CI 0.792–5.712, p = 0.134). CONCLUSIONS: Myocardial injury is a common and serious complication in hospitalized COVID-19 patients, associated with increased in-hospital mortality. However, it does not significantly impact long-term mortality in successfully discharged COVID-19 patients. Frontiers Media S.A. 2023-08-01 /pmc/articles/PMC10433191/ /pubmed/37600048 http://dx.doi.org/10.3389/fcvm.2023.1202332 Text en © 2023 Vu, Nguyen, Pham, Pham, Le and Le. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Vu, Vu Hoang Nguyen, Thanh Cong Pham, Quang Dang Duy Pham, Dan Ngoc Le, Le Bao Le, Khoi Minh Prevalence and impact of myocardial injury among patients hospitalized with COVID-19 |
title | Prevalence and impact of myocardial injury among patients hospitalized with COVID-19 |
title_full | Prevalence and impact of myocardial injury among patients hospitalized with COVID-19 |
title_fullStr | Prevalence and impact of myocardial injury among patients hospitalized with COVID-19 |
title_full_unstemmed | Prevalence and impact of myocardial injury among patients hospitalized with COVID-19 |
title_short | Prevalence and impact of myocardial injury among patients hospitalized with COVID-19 |
title_sort | prevalence and impact of myocardial injury among patients hospitalized with covid-19 |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433191/ https://www.ncbi.nlm.nih.gov/pubmed/37600048 http://dx.doi.org/10.3389/fcvm.2023.1202332 |
work_keys_str_mv | AT vuvuhoang prevalenceandimpactofmyocardialinjuryamongpatientshospitalizedwithcovid19 AT nguyenthanhcong prevalenceandimpactofmyocardialinjuryamongpatientshospitalizedwithcovid19 AT phamquangdangduy prevalenceandimpactofmyocardialinjuryamongpatientshospitalizedwithcovid19 AT phamdanngoc prevalenceandimpactofmyocardialinjuryamongpatientshospitalizedwithcovid19 AT lelebao prevalenceandimpactofmyocardialinjuryamongpatientshospitalizedwithcovid19 AT lekhoiminh prevalenceandimpactofmyocardialinjuryamongpatientshospitalizedwithcovid19 |